DDD Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-247,344
Closed -$22.2M 119
2025
Q1
$22.2M Sell
247,344
-6,671
-3% -$597K 2.7% 13
2024
Q4
$20.3M Sell
254,015
-9,394
-4% -$813K 2.49% 18
2024
Q3
$23.7M Buy
263,409
+33,584
+15% +$2.83M 2.58% 12
2024
Q2
$18.1M Buy
229,825
+828
+0.4% +$67.9K 2.1% 21
2024
Q1
$20M Buy
228,997
+11,835
+5% +$1.01M 2.44% 19
2023
Q4
$17.9M Sell
217,162
-1,208
-0.6% -$92.1K 2.4% 19
2023
Q3
$15.6M Sell
218,370
-4,029
-2% -$337K 2.25% 21
2023
Q2
$19.6M Buy
222,399
+2,006
+0.9% +$173K 2.71% 8
2023
Q1
$17.8M Buy
220,393
+2,153
+1% +$175K 2.77% 13
2022
Q4
$17M Buy
+218,240
New +$17.7M 2.71% 17

Other funds holding MDT

DDD Partners's MDT Position: Q2 2025 in Review

DDD Partners sold out of Medtronic (MDT) in Q2 2025, closing a stake of 247,344 shares — an estimated $22.2M sold.

DDD Partners first reported a position in MDT in Q4 2022 and held it in 10 quarters. The position peaked at $23.7M in Q3 2024. 2,139 funds tracked by Wall St. Rank hold MDT as of Q2 2025.

  • DDD Partners reported no remaining Medtronic position as of Q2 2025 after selling out during the quarter.
  • DDD Partners sold 247,344 Medtronic shares in Q2 2025, an estimated $22.2M.
  • DDD Partners first reported a position in Medtronic in Q4 2022 and held it in 10 quarters.
  • DDD Partners's Medtronic position peaked at $23.7M in Q3 2024.
  • 2,139 funds tracked by Wall St. Rank held Medtronic as of Q2 2025.

Based on DDD Partners's 13F filing for Q2 2025, filed 31 Jul 2025.